These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6278361)

  • 1. Isotachophoresis quantitation of subfractions of multiple sclerosis intra-blood-brain barrier IgG synthesis modulated by ACTH and/or steroids.
    Tourtellotte WW; Potvin AR; Ma BI; Baumhefner RW; Walsh MJ; Dickstein P; Ingram T; Cowan T; Shapshak P; Delmotte P
    Neurology; 1982 Mar; 32(3):261-6. PubMed ID: 6278361
    [No Abstract]   [Full Text] [Related]  

  • 2. Azathioprine and steroids are not more effective in decreasing multiple sclerosis intra-blood-brain-barrier IgG synthesis than steroids alone.
    Staugaitis SM; Shapshak P; Myers LW; Ellison GW; Tourtellotte WW; Lee M
    Ann Neurol; 1985 Sep; 18(3):356-7. PubMed ID: 2996418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The behavior of serum immunoglobulins in multiple sclerosis during anti-inflammatory therapy].
    Paltrinieri E; Giovannucci M
    Acta Neurol (Napoli); 1969; 24(4):613-25. PubMed ID: 4101181
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of ACTH therapy on IgG synthesis in cerebrospinal fluid spaces in patients with disseminated sclerosis].
    Wender M; Michałowska G; Wajgt A
    Neurol Neurochir Pol; 1986; 20(5):437-43. PubMed ID: 3035406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic trials of multiple sclerosis and intrathecal IgG production.
    Wender M; Tokarz E; Michalowska G; Wajgt A
    Ital J Neurol Sci; 1986 Apr; 7(2):205-8. PubMed ID: 3013800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multiple sclerosis. 6. Treatment with steroids].
    Gårde A
    Lakartidningen; 1970 Jul; 67(29):3307-8. PubMed ID: 4318039
    [No Abstract]   [Full Text] [Related]  

  • 7. [The immune status as an indicator for parameter-dependent therapy of multiple sclerosis?].
    Kuppe G; Schmidt RM; Ludewig R
    Nervenarzt; 1989 Sep; 60(9):549-52. PubMed ID: 2812159
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in serum immunoglobulin concentrations in patients with multiple sclerosis during the treatment with ACTH.
    Maciejek Z; Rebeś Z; Kubasiewicz B
    Arch Immunol Ther Exp (Warsz); 1981; 29(2):141-4. PubMed ID: 6272663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of multiple sclerosis].
    Arasa F
    Folia Clin Int (Barc); 1969 Jan; 19(1):7-23. PubMed ID: 4308450
    [No Abstract]   [Full Text] [Related]  

  • 10. Cellular immunity in multiple sclerosis. Implications for pathogenesis and treatment.
    Thompson RF; Davenport J
    Mo Med; 1984 Oct; 81(10):669-73. PubMed ID: 6092887
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple sclerosis de novo CNS IgG synthesis. Effect of CNS irradiation.
    Tourtellotte WW; Potvin AR; Baumhefner RW; Potvin JH; Ma BI; Syndulko K; Petrovich Z
    Arch Neurol; 1980 Oct; 37(10):620-4. PubMed ID: 6252876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cyclophosphamide in the therapy of multiple sclerosis].
    Salvatores U; Majeron M; Mascetti A
    Riv Sper Freniatr Med Leg Alien Ment; 1972 Feb; 96(1):163-84. PubMed ID: 4337775
    [No Abstract]   [Full Text] [Related]  

  • 13. Is steroid therapy in multiple sclerosis superior to corticotropin therapy?
    Davis FA; Stefoski D
    Arch Neurol; 1988 Nov; 45(11):1180. PubMed ID: 2847693
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple sclerosis de novo CNS IgG synthesis: effect of ACTH and corticosteroids.
    Tourtellotte WW; Baumhefner RW; Potvin AR; Ma BI; Potvin JH; Mendez M; Syndulko K
    Neurology; 1980 Nov; 30(11):1155-62. PubMed ID: 6252511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current status of multiple sclerosis intra-blood-brain-barrier IgG synthesis.
    Tourtellotte WW; Walsh MJ; Baumhefner RW; Staugaitis SM; Shapshak P
    Ann N Y Acad Sci; 1984; 436():52-67. PubMed ID: 6398024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schemes to eradicate the multiple sclerosis central nervous system immune reaction.
    Tourtellotte WW; Murthy K; Brandes D; Sajben N; Ma B; Comiso P; Potvin A; Costanza A; Korelitz J
    Neurology; 1976 Jun; 26(6 PT 2):59-61. PubMed ID: 179031
    [No Abstract]   [Full Text] [Related]  

  • 17. Corticotropin is superior to corticosteroids in the treatment of MS.
    Poser CM
    Arch Neurol; 1989 Sep; 46(9):946. PubMed ID: 2549925
    [No Abstract]   [Full Text] [Related]  

  • 18. Rate of synthesis of IgG within the blood-brain barrier and the IgG index compared in the diagnosis of multiple sclerosis.
    Hische EA; van der Helm HJ
    Clin Chem; 1987 Jan; 33(1):113-4. PubMed ID: 3802456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment with corticoids in multiple sclerosis].
    Fernández O
    Neurologia; 1990; 5(7):233-7. PubMed ID: 1963068
    [No Abstract]   [Full Text] [Related]  

  • 20. [Steroid therapy using ACTH or corticoids? Indications, effectiveness, and adverse effects of ACTH-therapy].
    Hannemann HR
    Med Klin; 1974 Mar; 69(13):513-24. PubMed ID: 4364747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.